Quercetin protects against the Aβ25-35-induced amnesic injury: Involvement of inactivation of RAGE-mediated pathway and conservation of the NVU

Neuropharmacology

Volumn 67, Issue , 2013, Pages 419-431

  Liu, Rui ^a   Zhang, Tian Tai ^a   Zhou, Dan ^a   Bai, Xiao Yu ^a   Zhou, Wei Ling ^a   Huang, Chao ^a   Song, Jun Ke ^a   Meng, Fang Rui ^a,b   Wu, Cai Xia ^a,c   Li, Lin ^d   Du, Guan Hua ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b LIAONING UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid peptide; The blood brain barrier; The neurovascular unit; The receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; QUERCETIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; IMMUNOFLUORESCENCE TEST; LEARNING CURVE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MICROVASCULARIZATION; MOUSE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMNESIA; AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL CORTEX; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEURAL PATHWAYS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; QUERCETIN; RECEPTORS, IMMUNOLOGIC;

EID: 84873380843     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.11.018     Document Type: Article

References (90)

1. N.J. Abbott Astrocyte-endothelial interactions and blood-brain barrier permeability J. Anat. 200 2002 629 638
2. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology Neurochem. Int. 4 2004 545 552
3. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
4. M.A. Ansari, H.M. Abdul, G. Joshi, W.O. Opii, and D.A. Butterfield Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease J. Nutr. Biochem. 20 2009 269 275
5. M.M. Appeldoorn, D.P. Venema, T.H. Peters, M.E. Koenen, I.C. Arts, J.P. Vincken, H. Gruppen, J. Keijer, and P.C. Hollman Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro J. Agric. Food Chem. 57 2009 7693 7699
6. S. Arancibia, A. Lecomte, F. Rage, M. Silhol, E. Aliaga, and L. Tapia Arancibia In vivo BDNF release and TrkB receptors expression in the supraoptic nucleus after osmotic stress stimulus in rats Neuroscience 146 2007 864 873
7. F. Arredondo, C. Echeverry, J.A. Abin-Carriquiry, F. Blasina, K. Antúnez, D.P. Jones, Y.M. Go, Y.L. Liang, and F. Dajas After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult Free Radic. Biol. Med. 49 2010 738 747
8. A. Barco, C.H. Bailey, and E.R. Kandel Common molecular mechanisms in explicit and implicit memory J. Neurochem. 97 2006 1520 1533
9. S. Bastianetto, and R. Quirion Natural extracts as possible protective agents of brain aging Neurobiol. Aging 23 2002 891 897
10. P. Bekinschtein, M. Cammarota, L.M. Igaz, L.R. Bevilaqua, I. Izquierdo, and J.H. Medina Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus Neuron 53 2007 261 277
11. V.P. Bindokas, J. Jordán, C.C. Lee, and R.J. Miller Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine J. Neurosci. 16 1996 1324 1336
12. F. Block Global ischemia and behavioural deficits Prog. Neurobiol. 58 1999 279 295
13. S. Boncristiano, M.E. Calhoun, P.H. Kelly, M. Pfeifer, L. Bondolfi, M. Stalder, A.L. Phinney, D. Abramowski, C. Sturchler-Pierrat, B. Enz Sommer, M. Staufenbiel, and M. Jucker Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis J. Neurosci. 22 2002 3234 3243
14. J. Bournival, P. Quessy, and M.G. Martinoli Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons Cell. Mol. Neurobiol. 29 2009 1169 1180
15. V. Calderone, S. Chericoni, C. Martinelli, L. Testai, A. Nardi, I. Morelli, M.C. Breschi, and E. Martinotti Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels Naunyn. Schmiedebergs. Arch. Pharmacol. 370 2004 290 298
16. T.J. Carew Molecular enhancement of memory formation Neuron 16 1996 5 8
17. V. Chander, D. Singh, and K. Chopra Reversal of experimental myoglobinuric acute renal failure in rats by quercetin, a bioflavonoid Pharmacology 73 2005 49 56
18. C.K. Chen, and C.R. Pace-Asciak Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta Gen. Pharmacol. 27 1996 363 366
19. N. Cho, J.H. Choi, H. Yang, E.J. Jeong, K.Y. Lee, Y.C. Kim, and S.H. Sung Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines Food Chem. Toxicol. 50 2012 1940 1945
20. J.T. Coyle, D.L. Price, and M.R. Delong Alzheimer's disease: a disorder of central cholinergic innervation Science 219 1983 1184 1190
21. M. Comalada, D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez, and A. Zarzuelo In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway Eur. J. Immunol. 35 2005 584 592
22. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat. Med. 9 2003 907 913
23. G.J. Del Zoppo The neurovascular unit in the setting of stroke J. Intern. Med. 267 2010 156 171
24. M.V. Eberhardt, C.Y. Lee, and R.H. Liu Antioxidant activity of fresh apples Nature 405 2000 903 904
25. V. Echeverria, D.E. Berman, and O. Arancio Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical nerurons Curr. Alzheimer Res. 4 2007 518 521
26. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
27. F. Fang, L.F. Lue, S. Yan, H. Xu, J.S. Luddy, D. Chen, D.G. Walker, D.M. Stern, S. Yan, A.M. Schmidt, J.X. Chen, and S.S. Yan RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease FASEB J. 24 2010 1043 1055
28. Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Antioxidant therapy in acute central nervous system injury: current state Pharmacol. Rev. 54 2002 271 284
29. B.H. Han, M.L. Zhou, F. Abousaleh, R.P. Brendza, H.H. Dietrich, J. Koenigsknecht-Talboo, J.R. Cirrito, E. Milner, D.M. Holtzman, and G.J. Zipfel Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition J. Neurosci. 28 2008 13542 13550
30. S.A. Heldt, L. Stanek, J.P. Chhatwal, and K.J. Ressler Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories Mol. Psychiatry 12 2007 656 670
31. H.C. Hendrie Epidemiology of Alzheimer's disease Geriatrics 52 1997 S4 S8
32. Y. Hou, M.A. Aboukhatwa, D.L. Lei, K. Manaye, I. Khan, and Y. Luo Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice Neuropharmacology 58 2010 911 920
33. C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease Nat. Rev. Neurosci. 5 2004 347 360
34. K. Ishige, D. Schubert, and Y. Sagara Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms Free Radic. Biol. Med. 30 2001 433 446
35. W.Y. Jung, S.J. Park, D.H. Park, J.M. Kim, D.H. Kim, and J.H. Ryu Quercetin impairs learning and memory in normal mice via suppression of hippocampal phosphorylated cyclic AMP response element-binding protein expression Toxicol. Lett. 197 2010 97 105
36. R.N. Kalaria Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease Neurobiol. Aging 30 2009 1512 1514
37. T.K. Kao, Y.C. Ou, S.L. Raung, C.Y. Lai, S.L. Liao, and C.J. Chen Inhibition of nitric oxide production by quercetin in endotoxin/cytokine- stimulated microglia Life Sci. 86 2010 315 321
38. J.F. Kelly, K. Furukawa, S.W. Barger, M.R. Rengen, R.J. Mark, E.M. Blanc, G.S. Roth, and M.P. Mattson Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons Proc. Natl. Acad. Sci. U.S.A 93 1996 6753 6758
39. D.H. Kim, E.A. Jung, I.S. Sohng, J.A. Han, T.H. Kim, and M.J. Han Intestinal bacterial metabolism of flavonoids and its relation to some biological activities Arch. Pharm. Res. 21 1998 17 23
40. D.H. Kim, S. Kim, S.J. Jeon, K.H. Son, S. Lee, B.H. Yoon, J.H. Cheong, K.H. Ko, and J.H. Ryu The effects of acute and repeated oroxylin A treatments on Aβ25-35-induced memory impairment in mice Neuropharmacology 55 2008 639 647
41. H. Kim, B.S. Park, K.G. Lee, C.Y. Choi, S.S. Jang, Y.H. Kim, and S.E. Lee Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid J. Agric. Food Chem. 53 2005 8537 8541
42. S.E. Laursen, and J.K. Belknap Intracerebroventricular injections in mice. Some methodological refinements J. Pharmacol. Methods 16 1986 355 357
43. B.H. Lee, S.H. Choi, T.J. Shin, M.K. Pyo, S.H. Hwang, S.M. Lee, H.D. Paik, H.C. Kim, and S.Y. Nah Effects of quercetin on α9α10 nicotinic acetylcholine receptor-mediated ion currents Eur. J. Pharmacol. 650 2011 79 85
44. B.H. Lee, S.H. Hwang, S.H. Choi, T.J. Shin, J. Kang, S.M. Lee, and S.Y. Nah Quercetin inhibits α3β4 nicotinic acetylcholine receptor-mediated ion currents expressed in Xenopus oocytes Korean J. Physiol. Pharmacol. 15 2011 17 22
45. J.H. Li, W. Wang, X.R. Huang, M. Oldfield, A.M. Schmidt, M.E. Cooper, and H.Y. Lan Advanced glycation end products induce tubular epithelial- myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway Am. J. Pathol. 164 2004 1389 1397
46. C. Lim, M.P. Alexander, G. Lafleche, D.M. Schnyer, and M. Verfaellie The neurological and cognitive sequelae of cardiac arrest Neurology 63 2004 1774 1778
47. A.L. Liu, S.H. Shu, H.L. Qin, S.M. Lee, Y.T. Wang, and G.H. Du In vitro anti-influenza viral activities of constituents from Caesalpinia sappan Planta Med. 75 2009 337 339
48. R. Liu, M. Gao, G.F. Qiang, T.T. Zhang, X. Lan, J. Ying, and G.H. Du The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit Neuroscience 162 2009 1232 1243
49. R. Liu, C.X. Wu, D. Zhou, F. Yang, S. Tian, L. Zhang, T.T. Zhang, and G.H. Du Pinocembrin protects against beta-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis BMC Med. 10 2012 105
50. R. Liu, T. Zhang, H. Yang, X. Lan, J. Ying, and G. Du The flavonoid apigenin protects brain neurovascular coupling against amyloid-beta25-35-induced toxicity in mice J. Alzheimers Dis. 24 2011 85 100
51. M.A. Lovell, and W.R. Markesbery Amyloid beta peptide, 4-hydroxynonenal and apoptosis Curr. Alzheimer Res. 3 2006 359 364
52. J. Lu, D. Wu, Z. Zheng, Y. Zheng, B. Hu, and Z. Zhang Troxerutin protects against high cholesterol-induced cognitive deficits in mice Brain 134 2011 783 797
53. J. Lu, Y.L. Zheng, L. Luo, D.M. Wu, D.X. Sun, and Y.J. Feng Quercetin reverses d-galactose induced neurotoxicity in mouse brain Behav. Brain Res. 171 2006 251 260
54. E.K. Miller, D.J. Freedman, and J.D. Wallis The prefrontal cortex: categories, concepts and cognition Philos. Trans. R. Soc. Lond. B Biol. Sci. 357 2002 1123 1136
55. R. Morris Developments of a water-maze procedure for studying spatial learning in the rat J. Neurosci. Methods 11 1984 47 60
56. W. Nakdook, O. Khongsombat, P. Taepavarapruk, N. Taepavarapruk, and K. Ingkaninan The effects of Tabernaemontana divaricata root extract on amyloid beta-peptide 25-35 peptides induced cognitive deficits in mice J. Ethnopharmacol. 130 2010 122 126
57. J.A. Nicoll, M. Yamada, J. Frackowiak, B. Mazur-Kolecka, and R.O. Weller Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA. Position.statement Neurobiol. Aging 25 2004 589 597
58. R.U. Ostrovskaya, M.A. Gruden, N.A. Bobkova, R.D. Sewell, T.A. Gudasheva, A.N. Samokhin, S.B. Seredinin, W. Noppe, V.V. Sherstnev, and L.A. Morozova-Roche The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model J. Psychopharmacol. 21 2007 611 619
59. J. Pavia, J. Alberch, I. Alverez, A. Toledano, and M.L. de Ceballos Repeated intracerebroventricular administration of β-amyloid 25-35 to rats decreases muscarinic receptors in cerebral cortex Neurosci. Lett. 278 2000 69 72
60. Y. Persidsky, S.H. Ramirez, J. Haorah, and G.D. Kanmogne Blood-brain barrier: structural components and function under physiologic and pathologic conditions J. Neuroimmune Pharmacol. 1 2006 223 236
61. T.A. Pham, S. Impey, D.R. Storm, and M.P. Stryker CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period Neuron 22 1999 63 72
62. A.P. Rogerio, A. Kanashiro, C. Fontanari, E.V. da Silva, Y.M. Lucisano-Valim, E.G. Soares, and L.H. Faccioli Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma Inflamm. Res. 56 2007 402 408
63. G.C. Roman, and R.N. Kalaria Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia Neurobiol. Aging 27 2006 1769 1785
64. C. Rovira, N. Arbez, and J. Mariani Aβ(25-35) and Aβ(1-40) act on different calcium channels in CA1 hippocampal neurons Biochem. Biophys. Res. Commun. 296 2002 1317 1321
65. S. Saponara, G. Sgaragli, and F. Fusi Quercetin as a novel activator of L-type Ca(2+) channels in rat tail artery smooth muscle cells Br. J. Pharmacol. 135 2002 1819 1827
66. A. Sato, Y. Sato, and S. Uchida Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging Auton. Neurosci. 96 2002 13 19
67. H. Schroeter, J.P. Spencer, C. Rice-Evans, and R.J. Williams Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3 Biochem. J. 358 2001 547 557
68. D.R. Sharma, W.Y. Wani, A. Sunkaria, R.J. Kandimalla, D. Verma, S.S. Cameotra, and K.D. Gill Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats Neurotox. Res. 2012 10.1007/s12640-012-9351-6
69. V. Sharma, M. Mishra, S. Ghosh, R. Tewari, A. Basu, P. Seth, and E. Sen Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection Brain Res. Bull. 73 2007 55 63
70. H.K. Shin, P.B. Jones, M. Garcia-Alloza, L. Borrelli, S.M. Greenberg, B.J. Bacskai, M.P. Frosch, B.T. Hyman, M.A. Moskowitz, and C. Ayata Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain 130 2007 2310 2319
71. E.M. Sigurdsson, J.M. Lee, X.W. Dong, M.J. Hejna, and S.A. Lorens Bilateral injections of amyloid-β 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects Neurobiol. Aging 18 1997 591 608
72. B. Silva, P.J. Oliveira, A. Dias, and J.O. Malva Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults Neurotox. Res. 13 2008 265 279
73. L. Song, W. Che, W. Min-Wei, Y. Murakami, and K. Matsumoto Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress Pharmacol. Biochem. Behav. 83 2006 186 193
74. C. Sun, C. Liang, Y. Ren, Y. Zhen, Z. He, H. Wang, H. Tan, X. Pan, and Z. Wu Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways Basic Res. Cardiol. 104 2009 42 49
75. A. Taguchi, D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M.A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D.M. Stern, and A.M. Schmidt Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
76. L. Tong, R. Balazs, P.L. Thornton, and C.W. Cotman Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons J. Neurosci. 24 2004 6799 6809
77. C.D. Tweedle, B.K. Modney, and G.I. Hatton Ultrastructural changes in the rat neurohypophysis following castration and testosterone replacement Brain Res. Bull. 20 1988 33 38
78. W.J. Tyler, M. Alonso, C.R. Bramham, and L.D. Pozzo-Miller From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning Learn. Mem. 9 2002 224 237
79. D. Vauzour, G. Ravaioli, K. Vafeiadou, A. Rodriguez-Mateos, C. Angeloni, and J.P. Spencer Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyL-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols Arch. Biochem. Biophys. 476 2008 145 151
80. P.J. Whitehouse Paying attention to acetylcholine: the key to wisdom and quality of life? Prog. Brain Res. 145 2004 311 317
81. D.M. Wilcock, M.P. Vitek, and C.A. Colton Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease Neuroscience 159 2009 1055 1069
82. V. Wilquet, and B. De Strooper Amyloid-beta precursor protein processing in neurodegeneration Curr. Opin. Neurobiol. 14 2004 582 588
83. Y. Yao, D.D. Han, T. Zhang, and Z. Yang Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons Phytother. Res. 24 2010 136 140
84. K.A. Youdim, M.Z. Qaiser, D.J. Begley, C.A. Rice-Evans, and N.J. Abbott Flavonoid permeability across an in situ model of the blood-brain barrier Free Radic. Biol. Med. 36 2004 592 604
85. H. Zill, R. Günther, H.F. Erbersdobler, U.R. Fölsch, and V. Faist RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells Biochem. Biophys. Res. Commun. 288 2001 1108 1111
86. B.V. Zlokovic Neurovascular mechanisms of Alzheimer's neurodegeneration Trends Neurosci. 28 2005 202 208
87. B.V. Zlokovic The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 2008 178 201
88. B.V. Zlokovic New therapeutic targets in the neurovascular pathway in Alzheimer's disease Neurotherapeutics 5 2008 409 414
89. B.V. Zlokovic, S. Yamada, D. Holtzman, J. Ghiso, and B. Frangione Clearance of amyloid β-peptide from brain: transport or metabolism? Nat. Med. 6 2000 718 719
90. S. Zola-Morgan, L.R. Squire, and D.G. Amaral Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus J. Neurosci. 6 1986 2950 2967